Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17.

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

The sedate uptake of pulsed field ablation (PFA) in Europe failed to presage the enthusiasm that drove the technology’s extraordinarily rapid adoption in the U.S. in 2024. Used to treat atrial ...

Drugmakers signed deals worth at least $18 billion in combined value on Monday, the first day of the healthcare industry's ...

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable ...

AbbVie (ABBV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...

1Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts. 2Center for Cancer Research, Center for Regenerative Medicine, Massachusetts General, Boston, ...

The airline industry announced hundreds of new U.S. flights in 2024, and a Boston route is one of the most exciting for 2025, according to The Points Guy. David Slotnick, a contributing editor for ...

1Department of Pathology and Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. 2Broad Institute of Harvard and MIT, Cambridge, ...

Drug giant AbbVie has a significant option agreement ... Learn More » Aldeyra Therapeutics, Inc. is headquartered just outside of Boston in Lexington, MA. The company is focused on developing ...